Improving Hypertension Control in Safety-Net Settings: The Boston Hypertension Equity Alliance in Treatment
NCT06948838
This study is recruiting at 7 US sites in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
High blood pressure (BP) or hypertension (HTN) affects over 100 million individuals in the US, increasing the risk of adverse outcomes, including stroke, myocardial infarction (MI), and chronic kidney disease (CKD). Effective therapies include non-pharmacologic approaches and multiple medication classes. Successful HTN management requires ongoing patient engagement for BP monitoring and treatment intensification. Reaching this goal is challenging, and many patients with HTN do not have controlled BP.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Hypertension
- Hypertension Complicated
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Boston Medical Center
- Last updated on ClinicalTrials.gov
- September 30, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Massachusetts · 7
- Boston Healthcare for the Homeless (BHCHP) · Boston, MA
- Boston Medical Center Family Medicine · Boston, MA
- Boston Medical Center, General Internal Medicine primary care · Boston, MA
- Mattapan Community Health Center · Boston, MA
- Neighborhood Health · Boston, MA
- Manet Community Health Center · Quincy, MA
- Greater Roslindale Medical and Dental Center (GRMDC) · Roslindale, MA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.